TPST (Tempest Tx) Yalpi foyda marjasi

Tempest Therapeutics Corp (TPST) korporativ emblemasi va logotipi

Tempest Therapeutics (TPST) kompaniyasining strategik maqsadi innovatsion immun-dorilarni ishlab chiqish uchun yetakchi onkologlarni jalb qilishdan iborat. Tushumning foiz ko'rsatkichi sifatidagi yalpi foyda marjasi ushbu yo'ldagi progressni namoyish etadi, bunda 0.00 qiymati metrika darajasini aks ettiradi. To'siqlar sifatida savdo amalga oshirilmagan klinik sinovlar bosqichi hamda patentlarini monetizatsiya qilish uchun tartibga soluvchi organlarning roziligi yoki sanoat gigantlari bilan hamkorlikka bo'lgan bog'liqlik saqlanib qolmoqda.

TPST Tempest Therapeutics Corp Yalpi foyda bo'yicha rentabellik (04.07.2022 - 19.11.2026)

Tempest Tx (TPST) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

Tempest Therapeutics Inc tomonidan chiqariladigan mahsulotlar

Gross marjalarning tahlili Tempest Therapeutics (TPST) operatsion xarajatlarini uning daromad potentsiali bilan solishtirish imkonini beradi va bevosita ishlab chiqarish xarajatlari chegirilgandan keyin qolgan foyda ulushini aks ettiradi. Ushbu ko'rsatkich jipslashgan ilmiy jamoaning resurs samaradorligini o'lchaydi, bunda tadqiqot xodimlarining barqarorligi sotilgan tovarlar tannarxining oshish xavfini minimallashtiradi va institutsional investorlarga aktivning fundamental qiymatini baholash uchun ob'yektiv asosni taqdim etadi.

Toʻgʻridan-toʻgʻri raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Yalpi rentabellik RVMD|Yalpi foyda bo'yicha rentabellik AAPG (Ascentage)|Yalpi foyda bo'yicha rentabellik cgoncology.com CGON|UroGen Pharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi BCAX|PSNL - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Erasca Oncology ERAS|delcath.com (DCTH) - Yalpi rentabellik|Y-mAbs Therapeutics - Yalpi foyda normasi|AURA (Aura Biosciences Inc) - Yalpi marja|Yalpi foyda marjasi candeltx.com CADL|Yalpi marja ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Yalpi foyda normasi|Yalpi rentabellik Actuate Therapeutics, Inc. ACTU|citiusonc.com - Yalpi rentabellik|TuHURA Biosciences Inc. - Yalpi marja|TARA - Yalpi marja|FATE (Fate Therapeutics) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Aadi Bioscience, Inc.|Yalpi foyda bo'yicha rentabellik TCRX|Yalpi rentabellik CSBR|Yalpi marja XBIT|Yalpi foyda bo'yicha sotuv rentabelligi CEL-SCI Corp.|Yalpi rentabellik ostherapies.com OSTX|RADX: Sotuvning yalpi rentabelligi|ARTV: Yalpi foyda bo'yicha rentabellik|ANL (Adlai Nortye) - Sotuvning yalpi rentabelligi|Veru (VERU) - Yalpi rentabellik|XLO - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Renovaro|Yalpi marja muraloncology.com|Yalpi marja KAPA|Yalpi foyda bo'yicha sotuv rentabelligi OnKure Therapeutics, Inc.|Yalpi marja GDTC (w2.cytomed.sg)|CRIS - Yalpi foyda bo'yicha rentabellik|Apollomics - Yalpi marja|Tharimmune Corp (THAR) - Yalpi foyda bo'yicha rentabellik|ADVB: Yalpi marja|Yalpi foyda bo'yicha rentabellik Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Yalpi marja|Sotuvning yalpi rentabelligi SBFM (Sunshine Biopharma)|Yalpi rentabellik Xenetic Bio (XBIO)|Yalpi rentabellik SLRX (Salarius Pharma)|Kitov Pharma - Yalpi foyda bo'yicha rentabellik|American Oncology Network (AONC) - Yalpi foyda marjasi|BeiGene - Yalpi marja|Checkpoint Therapeutics, Inc. (CKPT) - Yalpi foyda bo'yicha rentabellik|ELEV (Elevation Oncology, Inc.) - Yalpi foyda bo'yicha rentabellik|iCAD Inc. - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik IKNA|Yalpi marja notablelabs.com|Yalpi foyda bo'yicha rentabellik VIRX (Viracta Therapeutics Inc.)|MOR - Yalpi foyda marjasi|Yalpi rentabellik NAYA Biosciences NAYA|AAPGV - Yalpi foyda bo'yicha rentabellik